NITI Aayog roadmap targets USD 691 bn bioeconomy by 2035; Jitendra Singh says India ready to lead biotech revolution 
News

Six new bio-missions to reshape academic research and commercial manufacturing in India

A comprehensive government roadmap outlines ambitious targets for biotechnology growth, proposing new engineering biology courses and a dedicated growth fund to drive industrial innovation

ANI

New Delhi [India], July 16 (ANI): India's bioeconomy can expand to USD 691 billion by 2035, create over 30 million high-value jobs and position the country among the world's top three biotechnology powers, according to a roadmap unveiled by NITI Aayog on Thursday, as Union Minister Dr Jitendra Singh said India is ready to take a leadership role in the next wave of biotechnology-driven growth.
Launching the Roadmap for Building India as a Leading Bioeconomy Powerhouse by 2035, Singh said the "fourth industrial revolution is being driven by biotechnology" and noted that the global bioeconomy market is currently valued at USD 1.4-1.8 trillion, while India already has more than 11,000 biotechnology startups.
"We are among the very few countries that have come out with a dedicated biotechnology policy," the minister said.
Highlighting India's ambitions in the sector, Singh added, "We are no longer waiting for others to experiment. We are ready to take risks and take risks with a certain amount of confidence."
The roadmap projects India's bioeconomy to grow further to USD 2.6 trillion by 2047, contributing 8-10 per cent of GDP, through a mission-driven strategy focused on biomanufacturing, AI-enabled biotechnology, regulatory reforms and stronger industry participation. It states that with decisive execution, India can emerge as one of the world's leading biotechnology hubs.
To support this transformation, the roadmap proposes six National BioMissions covering gene and cell therapies, climate-resilient agriculture, synthetic biology, disease surveillance, marine biotechnology and next-generation biopharmaceuticals. It also recommends creating a Rs 50,000-crore BioEconomy Growth Fund for 2026-2035 to help bridge the gap between laboratory research and commercial-scale manufacturing, alongside PLI-style incentives, faster regulatory approvals and stronger intellectual property protection.
Stressing the importance of developing domestic capabilities, Singh said talent development would be critical for building a sovereign biotechnology ecosystem.
"We are introducing a course in engineering biology, which will be the first of its kind in India... which could be the key to bioeconomy," he said.
The roadmap notes that India's bioeconomy has already grown 16-fold, from USD 10 billion in 2014 to USD 195.3 billion in 2025, contributing 4.8 per cent to GDP.
Summing up the broader vision, Singh said, "Once we have a thriving bioeconomy, we will be addressing more than one national goal... there will be health security, food security, Vocal for Local and also global, there will be high-skill jobs in millions and above all the geopolitical stature of India."

This report was published from a syndicated wire feed. Apart from the headline, the EdexLive Desk has not edited the copy.

Bengaluru: BTech student allegedly falls to death from university hostel building; police launch probe

FIR lodged against unidentified man for making 'obscene' gestures in JNU

UGC launches 'SheRNI' to ensure women scientist representation

Father of Kota student who killed self suspects foul play, demands fair probe

Gorakhpur NCC Academy will inspire youth to contribute to nation-building: UP CM Adityanath